COHR
Coherent, Inc.
COHR's fundamentals are strong: revenue grew 31% and its operating margin rose 8 points to 13%, though free cash flow turned negative. At 48x earnings, it's trading above its usual 34x. Analysts expect that strong growth to continue.
CRCL
Circle Internet Group
There isn't enough reported data to score CRCL yet.
COHR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Weak | |
| Healthy |
COHR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CRCL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
CRCL's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRCL.
COHR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $232 | — |
| Cheap | 27x | $130 | -44% |
| Fair | 34x | $165 | -29% |
| Current | 48x | $232 | — |
| Expensive | 184x | $886 | +282% |
Historical ranges are pointers, not guarantees.
COHR's PE is in its fair range at 48x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its cheap range.
CRCL PE Valuation
CRCL has no meaningful PE right now: it lost money over the past year.
COHR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for COHR, with profitability improving.
CRCL Forward outlook
There aren't enough analyst estimates for CRCL to show an outlook.
COHR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.69 | +142% |
| Q3 2026 | $4.83 | +580% |
| Q2 2026 | $4.12 | +$4.64 |
| Q1 2026 | $2.11 | +$2.34 |
| Q4 2025 | $1.03 | +$1.44 |
| Q3 2025 | $0.71 | +$1.94 |
| Q2 2025 | -$0.52 | +$1.32 |
| Q1 2025 | -$0.23 | +$2.64 |
| Q4 2024 | -$0.41 | +$2.41 |
COHR's earnings per share have climbed steadily: $4.83 over the past year, about seven times what it earned the year before, and higher year over year for 10 quarters in a row.
CRCL Earnings Per Share
CRCL and COHR do not have enough comparable growth data to identify a winner.
COHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.4B | +50% |
| Q2 2026 | $2B | +34% |
| Q1 2026 | $1.8B | +21% |
| Q4 2025 | $1.7B | +17% |
| Q3 2025 | $1.6B | +17% |
| Q2 2025 | $1.5B | +16% |
| Q1 2025 | $1.5B | +24% |
| Q4 2024 | $1.4B | +27% |
COHR's revenue has grown year over year for 10 quarters in a row: $2.4B last quarter, up 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +1.4 points |
| Q2 2026 | 14% | +18 points |
| Q1 2026 | 10% | +9.6 points |
| Q4 2025 | 10% | +1 points |
| Q3 2025 | 14% | +12 points |
| Q2 2025 | -4.2% | -9 points |
| Q1 2025 | 0.7% | -1.2 points |
| Q4 2024 | 8.9% | +6.1 points |
COHR's operating margin was 15% last quarter, up 1.4 points from the same quarter a year ago, near the top of its range since 2019.
CRCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $864.9M | +17% |
| Q2 2026 | $701.3M | +6.6% |
| Q1 2026 | $694.1M | +20% |
| Q4 2025 | $770.2M | +77% |
| Q3 2025 | $739.8M | +66% |
| Q2 2025 | $658.1M | +53% |
| Q1 2025 | $578.6M | +58% |
CRCL has the edge over COHR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +13 points |
| Q2 2026 | 4.9% | +54 points |
| Q1 2026 | 6.5% | -9.6 points |
| Q4 2025 | 7.2% | +7 points |
| Q3 2025 | 11% | -3.4 points |
| Q2 2025 | -49% | -61 points |
| Q1 2025 | 16% | +1.7 points |
| Q4 2024 | 0.2% | N/A |
CRCL has the edge over COHR on profitability, with a higher operating margin.
COHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$868.2M | -$810.2M |
| Q2 2026 | -$486.2M | -$485.2M |
| Q1 2026 | -$383.5M | -850% |
| Q4 2025 | -$95.7M | -217% |
| Q3 2025 | -$58M | -195% |
| Q2 2025 | -$1.1M | -102% |
| Q1 2025 | $51.1M | +111% |
| Q4 2024 | $81.7M | +$106M |
COHR's free cash flow has turned negative after years in the green: −$1.8B over the past year.
CRCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$35.6M | -$20.8M |
| Q1 2026 | $11.7M | -74% |
| Q4 2025 | $248.1M | +162% |
| Q3 2025 | -$14.7M | -114% |
| Q1 2025 | $44.9M | -34% |
CRCL's free cash flow was $741M over the past year, about three times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like CRCL.
COHR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.4% | +6.6M shares |
| 1 year | +5.9% | +11.3M shares |
| 3 years | +34% | +51.7M shares |
| 5 years | +74% | +86.2M shares |
| Available history | +122% | +111M shares |
COHR has the edge over CRCL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q2 2020 | — |
| Q1 2020 | $1,000 |
CRCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -861K shares |
| 1 year | +149% | +160M shares |
CRCL has 268M diluted shares, up 149% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
COHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 8.1x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 4.6x | High |
COHR's net debt is about 1.7 years of its operating earnings (EBITDA), down from 4.1 years a year ago.
CRCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.7x | Net Cash |
| Q2 2026 | -5.4x | Net Cash |
| Q1 2025 | -2.8x | Net Cash |
| Q4 2024 | -2.6x | Net Cash |
CRCL has the edge over COHR on leverage, with a lower net debt burden relative to earnings.
COHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 16.5 | Oversold |
COHR's weekly RSI is 44 (neutral) and its Stochastic is 16 (oversold).
CRCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.1 | Neutral |
| Stochastic | 19.0 | Oversold |
CRCL's weekly RSI is 40 (neutral) and its Stochastic is 19 (oversold).
COHR PE vs Technology Sector
| Metric | COHR | Sector median | Relative |
|---|---|---|---|
| PE | 48x | 28x | 72% above |
| PE % | 58 | 35 | 23 pts above |
COHR is trading at 48x earnings, a 72% premium to the Technology sector's median of 28x.
CRCL PE vs Financial Services Sector
CRCL has no meaningful PE right now: it lost money over the past year.
COHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $252.9 | 8.2% below |
| 20 week MA | $284.1 | 18% below |
| 50 week MA | $277.7 | 16% below |
| 100 week MA | $185.9 | 25% above |
| 200 week MA | $120.6 | 92% above |
COHR has stronger trend alignment. COHR is above 2 of 5 weekly averages versus CRCL above 0 of 3.
CRCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $78.4 | 19% below |
| 20 week MA | $77.1 | 17% below |
| 50 week MA | $84.2 | 24% below |
CRCL is in a downtrend: it's below all three of its weekly moving averages, and 24% below its 50-week average.
COHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.5 | $77.8 | +132% |
| 2021 | $77.8 | $68.0 | -13% |
| 2022 | $68.0 | $33.1 | -51% |
| 2023 | $33.1 | $43.5 | +32% |
| 2024 | $43.5 | $97.0 | +123% |
| 2025 | $97.0 | $191.7 | +98% |
| 2026 YTD | $191.7 | $232.1 | +21% |
COHR has the edge over CRCL on returns for 2026, with the stronger performance.
CRCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $107.7 | $81.3 | -25% |
| 2026 YTD | $81.3 | $63.8 | -21% |
CRCL has finished every year since 2025 lower, and it's down 21% so far in 2026.